Global® AP™ Total Shoulder Arthroplasty
Study Details
Study Description
Brief Summary
This study will evaluate the clinical performance of DePuy Global® AP™ Shoulder prosthesis using the anchor pegged glenoid component and clinical and radiographic evaluations.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The purpose of the study is to determine the difference between pre-operative and post-operative levels of patient satisfaction, shoulder function, radiographic alignment, shoulder pain and patient satisfaction in patients receiving a Global® AP™ shoulder prosthesis for glenohumeral arthritis.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Global® AP™ Shoulder Global® AP™ Shoulder |
Device: Global® AP™ Total shoulder arthroplasty
Total shoulder arthroplasty
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Constant Shoulder Score [Pre-op, 6, 12, 24 months]
Secondary Outcome Measures
- SF-12 [Pre-op, 6,12, 24 months]
- Penn/ASES [Pre-Op, 6, 12, and 24 months]
- Radiographic Data [Pre-Op, 6 weeks, 6, 12, and 24 months]
- Quality of Life Survey [6 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients selected for inclusion will present for primary shoulder arthroplasty with a diagnosis of osteoarthritis and will consent to participate.
Exclusion Criteria:
-
Are under 18 years of age or over 70
-
Diagnosis of AVN, Inflammatory Arthritis, Fracture or Malunion.
-
Have a hemi-arthroplasty
-
Have destruction of the proximal humerus that precludes rigid fixation of the humeral component
-
Have arthritis with insufficient cuff tissue
-
Have had a failed rotator cuff surgery
-
Have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified
-
Have evidence of active infection
-
Present with a condition of neuromuscular compromise of the shoulder (e.g., neuropathic joints or brachial plexus injury with a flail shoulder joint) - Have a known active metastatic or neoplastic disease
-
Are unwilling or unable to comply with a rehabilitation program or would fail to return for the postoperative follow-up visits prescribed by the protocol
-
Are skeletally immature.
-
Have a known allergic reaction to implant metals, polyethylene or a tissue reaction to corrosion or wear products
-
Have other conditions such as central nervous system disturbances, alcohol or drug addiction, etc. that may make effective evaluation of the joint replacement difficult or impossible
-
Are currently participating in another clinical study
-
Are taking > 10mg/day corticosteroids (e.g. prednisone) excluding inhalers, within 3 months prior to surgery
-
Are currently involved in any personal injury litigation, medical legal or worker's compensation claims.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The CORE Institute | Phoenix | Arizona | United States | 85027 |
2 | Mission Hospitals Research Institute | Asheville | North Carolina | United States | 28801 |
3 | Wellington Orthopaedics and Sports Medicine | Cincinnati | Ohio | United States | 45230 |
4 | Rosenberg Cooley Metcalf Clinic | Park City | Utah | United States | 84060 |
Sponsors and Collaborators
- DePuy Orthopaedics
Investigators
- Study Director: Sam Himden, BA, DePuy Orthopaedics
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 05071